A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
Manage episode 423322059 series 3551733
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.
11 episodes